Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001193125-26-015323

Chief Financial Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Adawi Kamal · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-15 Grant or award : show line 1 in the form +25,000 100,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-15 Grant or award : show line 2 in the form Stock Option (Right to Buy) +75,000 75,000 D
Loading xslF345X05/ownership.xml…